beta

AIKI

AIkido Pharma, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

Market Cap: 28.5 Million

Primary Exchange: NASDAQ

Website: http://www.aikidopharma.com

Shares Outstanding: 34.9 Million

Float: 33 Million

Dividend: (%)

Beta: -1.00424975018493

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 77 trading days

From: 2020-03-13 To: 2020-07-02

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud